Gary  Tse

Gary Tse 謝家偉

Gary Tse is a clinician-scientist with training in physiology, medicine, cardiac electrophysiology, public health and healthcare management. He started his medical and scientific training at the University of Cambridge in 2005. In 2007, he was awarded the Gregon and Benn Award (Trinity Hall, University of Cambridge) for research exchange to Yale University's Department of Biomedical Engineering. In 2008, Dr. Tse was selected for the Frankl Award (Trinity Hall, University of Cambridge), The Wellcome Trust and The Physiological Society Scholarships for cardiovascular research at Cambridge, and a Master's scholarship for MPhil study in Computational Biology from the Cambridge-MIT Institute, which he declined to take up a BBSRC CASE Collaborative Doctoral Training Award, as 1 of the 3 recipients across three Departments selected from an open recruitment exercise. Later, he conducted research in cardiovascular MRI at the Royal Brompton Hospital whilst undertaking clinical training at Imperial College London. He received his PhD in Systems Biology from the University of Cambridge in July 2015, MPH (Master of Public Health) from the University of Manchester in 2017 and MHM (Master of Health Management) from the University of New South Wales in 2018.

In August 2015, Dr. Tse was appointed Assistant Professor in Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong. In 2016, he took up The Croucher Foundation Clinical Assistant Professorship at the Faculty of Medicine of The Chinese University of Hong Kong. He is a Principal Investigator in the Faculty's Li Ka Shing Institute of Health Sciences. In 2018, Dr. Tse was appointed to Guest Professorship in Cardiovascular Medicine at the First Affiliated Hospital of Dalian Medical University. He also delivered lectures as Visiting Professor to the Second Affiliated Hospital of the Tianjin Medical University.

Dr. Tse has attracted HK$9.1 million research-related funding as a principal applicant and co-applicant. He has supervised over 70 medical and science students for medical research.

Education:

  • 2018   MHM (Healthcare Management), The University of New South Wales, Australia
  • 2017   MPH (Public Health Medicine), The University of Manchester, United Kingdom
  • 2015   PhD (Cardiac Electrophysiology), The University of Cambridge, United Kingdom
  • 2014   MBBS (Clinical Medicine), Imperial College London, United Kingdom
  • 2012   MA, The University of Cambridge, United Kingdom
  • 2008   BA (Hons) (Pre-clinical Medicine), The University of Cambridge, United Kingdom

Professional Memberships and Fellowships:

  • MFPH (UK) - Member by Distinction, Faculty of Public Health (2018)
  • FHRS - Fellow, Heart Rhythm Society (2018)
  • FACE - Fellow, American College of Epidemiology (2017)
  • FAcadTM - Fellow, Academy of Translational Medicine Professionals (2017)
  • FRCP (Glasgow) - Fellow, Royal College of Physicians and Surgeons of Glasgow (2017)
  • FACC - Fellow, American College of Cardiology (2017)
  • FESC - Fellow, European Society of Cardiology (2016)
  • FIBMS - Fellow, Institute of Biomedical Sciences (2016)
  • FRSPH - Fellow, Royal Society of Public Health (2016)
  • CSci - Chartered Scientist, The Science Council (2016)
  • FLS - Fellow, Linnean Society of London (2014)
  • FCPS - Fellow, Cambridge Philosophical Society (2009)
  • Member, Royal Society of Medicine (2005)

Current work

Dr. Tse has published more than 160 publications (83 as first/co-first/corresponding/co-corresponding author; citations: 1135; h-index = 23) in leading international journals, such as European Heart Journal, Journal of the American College of Cardiology, JACC: Clinical Electrophysiology, Journal of the American Medical Directors Association, Circulation: Arrhythmia and Electrophysiology, International Journal of Cardiology, Stroke, Heart, Journal of the American Heart Association, Heart Rhythm, Acta Physiologica (Oxford), Europace, Frontiers in Physiology, Journal of Arrhythmia etc. on the following research themes:

1. Pre-clinical and clinical cardiac electrophysiology, particularly stratification of arrhythmic risk in congenital ion channelopathies

2. Inflammation and endothelial dysfunction and cardiac remodelling